Intus Biosciences
Organisation
People
Chief scientific officer
Sources: reporter.nih.gov
Grants and prizes
R44, Non-Invasive, Bacterial-Based Early-Onset Colorectal Screen, R44CA314644, US$404.3k, 2026–2027, 18 Aug 2026
R43, Breakthrough High-Accuracy, High-Throughput Colorectal Cancer Screening Platform, R43CA298515, US$406k, 2025–2027, 24 Jul 2025
Sources: reporter.nih.gov